T. Rowe Price Associates’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
137,890
+2,192
| +2% | +$294K | ﹤0.01% | 977 |
|
|
2025
Q1 | $9.13M | Sell |
135,698
-122,947
| -48% | -$8.27M | ﹤0.01% | 1131 |
|
|
2024
Q4 | $16.1M | Sell |
258,645
-34,821
| -12% | -$2.17M | ﹤0.01% | 1034 |
|
|
2024
Q3 | $46.1M | Sell |
293,466
-36,968
| -11% | -$5.8M | 0.01% | 777 |
|
|
2024
Q2 | $49.8M | Buy |
330,434
+33,110
| +11% | +$4.99M | 0.01% | 727 |
|
|
2024
Q1 | $22M | Buy |
297,324
+22,223
| +8% | +$1.64M | ﹤0.01% | 954 |
|
|
2023
Q4 | $21.7M | Buy |
275,101
+153,861
| +127% | +$12.1M | ﹤0.01% | 933 |
|
|
2023
Q3 | $6.64M | Buy |
121,240
+105,319
| +662% | +$5.77M | ﹤0.01% | 1128 |
|
|
2023
Q2 | $1.34M | Buy |
15,921
+880
| +6% | +$74K | ﹤0.01% | 1648 |
|
|
2023
Q1 | $1.14M | Buy |
15,041
+529
| +4% | +$40.1K | ﹤0.01% | 1723 |
|
|
2022
Q4 | $896K | Buy |
14,512
+288
| +2% | +$17.8K | ﹤0.01% | 1829 |
|
|
2022
Q3 | $594K | Buy |
14,224
+5,803
| +69% | +$242K | ﹤0.01% | 2039 |
|
|
2022
Q2 | $265K | Buy |
8,421
+171
| +2% | +$5.38K | ﹤0.01% | 2488 |
|
|
2022
Q1 | $222K | Sell |
8,250
-178,013
| -96% | -$4.79M | ﹤0.01% | 2668 |
|
|
2021
Q4 | $3.57M | Buy |
+186,263
| New | +$3.57M | ﹤0.01% | 1550 |
|
|
2021
Q1 | – | Sell |
-336,789
| Closed | -$6.7M | – | 2867 |
|
|
2020
Q4 | $6.7M | Sell |
336,789
-89,442
| -21% | -$1.78M | ﹤0.01% | 1401 |
|
|
2020
Q3 | $5.87M | Buy |
426,231
+185
| +0% | +$2.55K | ﹤0.01% | 1385 |
|
|
2020
Q2 | $7.64M | Sell |
426,046
-33,080
| -7% | -$593K | ﹤0.01% | 1336 |
|
|
2020
Q1 | $5.55M | Sell |
459,126
-62,495
| -12% | -$755K | ﹤0.01% | 1328 |
|
|
2019
Q4 | $9.92M | Buy |
+521,621
| New | +$9.92M | ﹤0.01% | 1313 |
|